ROBERTA LAY: Open Payments
NPI 1154488955 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 56 payments from 11 companies in 2025. Trend: 2023 $441 · 2024 $548 · 2025 $1,005
Food & beverage: $1,005
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $302 |
| Aimmune Therapeutics, Inc. | 16 | $232 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $132 |
| Gilead Sciences, Inc. | 5 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Janssen Biotech, Inc. | 2 | $46 |
| Madrigal Pharmaceuticals | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Lilly USA, LLC | 1 | $25 |
| PFIZER INC. | 1 | $21 |
Products named: VOWST, SKYRIZI, ZENPEP, ENTYVIO, DUPIXENT, EOHILIA, CREON, LINZESS.
Industry payments across OH — which companies pay providers there.
